PULMONARY HYPERTENSION (PH) -> PH - Pulmonary Arterial Hypertension Abstracts

16 - Validation of REVEAL Risk Score Calculator 2.0 in Patients with PAH in the Phase III PATENT Study

Presentation Number
16
Speakers
Session Name
SESSION 05 - ORAL: Pulmonary Hypertension: Where We're Going We Don't Need Roads
Date
Wed, Apr 22, 2020
Time
10:30 AM - 12:15 PM
Authors

Previous ePresentation
14 - INSPIRE: Final Results from a Phase 3, Open-Label, Pivotal Study to Evaluate the Safety and Tolerability of LIQ861 in Pulmonary Arterial Hypertension

Next ePresentations
18 - Right Atrial Pacing to Improve Acute Hemodynamics in Pulmonary Arterial Hypertension
20 - To B or Not To Be, That is the Question...
26 - Rapid Activation of Pro-Lymphangiogenic Phenotype and Consequent Increase of Lymphatic Density Occurs during the Development of Chronic Lung Allograft Dysfunction
35 - Survival and Predictors of Mortality in Patients Undergoing RVAD Explant in IMACS
38 - The Unique Impact of Blood Type O on Gastrointestinal Bleeding with Left Ventricular Assist Systems
39 - Dysregulation of the Angiopoietin-2/Tie-2 Axis is Associated with Reduced Pulsatility and Increased Arteriovenous Malformation Related Gastrointestinal Bleeding Following Left Ventricular Assist Device Implantation
41 - Association of Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers on LVAD Support and Risk of Gastrointestinal Bleeding: A Multi-Center Analysis
42 - Association between Digoxin Use and Gastrointestinal Bleeding in Contemporary Continuous Flow Left Ventricular Assist Device Support
44 - Role of Anti-Vimentin Antibodies in Pre-Sensitized Korean Heart Transplant Patients
46 - The Natural History of Pre-Existing Donor Specific Antibody and Amnestic Responses after Heart Transplantation